FDA Inspection 850011 — Bioamazonic, Inc.

Bioamazonic, Inc. — FEI 3005583861

The FDA completed an inspection of Bioamazonic, Inc. on Oct 21, 2013 in Hialeah Gardens, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 15 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 21, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hialeah Gardens, FL (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
154021 CFR 211.125(a)Strict control not exercised over labeling issued
1540421 CFR 111.12(c)Personnel - education, training, experience
1564121 CFR 111.453Written procedures - holding
1576321 CFR 111.205(a)Master manufacturing record - unique formulation
1579021 CFR 111.403Written procedures - labeling operations
1579721 CFR 111.553Written procedures - product complaint
1582821 CFR 111.70(a)Specifications - manufacturing process
1582921 CFR 111.70(b)(1)Specifications - component identity
1592721 CFR 111.103Written procedures - quality control operations
1605821 CFR 111.535(b)(2)Records - ret'nd dietary supplement: material review, dispos
241921 CFR 211.198(a)Complaint Handling Procedure
433621 CFR 211.150Written distribution procedure
54121 CFR 820.70(c)Environmental control Lack of or inadequate procedures
900121 CFR 211.22(a)Lack of quality control unit